VRC-HIVDNA009-00-VP
Latest Information Update: 30 Oct 2021
At a glance
- Originator National Institute of Allergy and Infectious Diseases; Vaccine Research Center
- Developer HIV Vaccine Trials Network; National Institute of Allergy and Infectious Diseases
- Class AIDS vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 Jun 2017 GenVec has been acquired by Intrexon Corporation